Leonteq Securities’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$197K Buy
959
+322
+51% +$63.8K 0.01% 507
2026
Q2
$119K Buy
+637
New +$93K ﹤0.01% 663
2026
Q1
– Sell
-300
Closed -$23.9K – 1461
2025
Q4
$23.9K Buy
+300
New +$19.7K ﹤0.01% 1060
2025
Q1
– Sell
-479
Closed -$21K – 1331
2024
Q4
$21K Sell
479
-55
-10% -$2.78K ﹤0.01% 964
2024
Q3
$24.2K Sell
534
-100
-16% -$4.35K ﹤0.01% 888
2024
Q2
$24.6K Buy
634
+449
+243% +$16.8K ﹤0.01% 893
2024
Q1
$5.96K Buy
+185
New +$5.48K ﹤0.01% 1062

Other funds holding RVMD

Leonteq Securities's RVMD Position: Q3 2026 in Review

Leonteq Securities increased its Revolution Medicines (RVMD) stake by 51% in Q3 2026, buying an estimated $63.8K and bringing the position to 959 shares worth $197K. The position accounts for 0.01% of the portfolio, ranked #507.

Leonteq Securities first reported a position in RVMD in Q1 2024 and has held it in 7 quarters since. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Leonteq Securities held 959 shares of Revolution Medicines worth $197K as of Q3 2026.
  • Leonteq Securities bought 322 Revolution Medicines shares in Q3 2026, an estimated $63.8K.
  • Revolution Medicines made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #507 holding.
  • Leonteq Securities first reported a position in Revolution Medicines in Q1 2024 and has held it in 7 quarters since.
  • 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.